Fmoc-L-citrulline

Fmoc-L-citrulline is an Fmoc-protected, naturally occurring amino acid derivative featuring the L-citrulline backbone with a ureido-containing side chain and both an amino group and a carboxyl group masked for peptide chemistry. The N-terminus is protected as an Fmoc carbamate, while the side-chain ureido functionality provides a polar, hydrogen-bonding-rich group that can influence coupling and subsequent peptide properties. In synthesis, this protected amino acid is used as a building block for stepwise peptide assembly, including solid-phase peptide synthesis, where the protecting group supports chemoselective formation of peptide bonds and the ureido side chain can be carried through to generate citrulline-containing peptide targets.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Fmoc-L-citrulline(CAS 133174-15-9)

CAT No: CP04704

CAS No:133174-15-9

Synonyms/Alias:Fmoc-Cit-OH;133174-15-9;Fmoc-L-citrulline;L-Ornithine, N5-(aminocarbonyl)-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-ureidopentanoic acid;Nalpha-Fmoc-L-citrulline;(2S)-5-(carbamoylamino)-2-(9H-fluoren-9-ylmethoxycarbonylamino)pentanoic acid;DTXSID10373252;MFCD00151943;(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-ureidopentanoic acid;(2S)-5-(carbamoylamino)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pentanoic acid;fmoc-citoh;N-Fmoc-L-citrulline;SCHEMBL119468;Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-citrulline;DTXCID10324284;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-ureido-pentanoic acid;AKOS015837234;AKOS015895285;AC-8677;CS-W008064;FF10665;HY-W008064;Fmoc-Cit-OH, >=97.0% (HPLC);AS-17492;DB-038068;F0626;EN300-316936;M03232;S-133174-15-9;N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-citrulline (Fmoc-L-Cit-OH);(2S)-5-(carbamoylamino)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pentanoic acid;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C21H23N3O5
M.W/Mr.
397.4
Sequence
Three Letter Code:Fmoc-Cit-OH
Application
Peptide synthesis; Drug screening

Fmoc-L-citrulline is an Fmoc-protected L-citrulline amino acid derivative featuring the ureido side chain characteristic of arginine-family chemistry, with a stereogenic center at the alpha carbon in the L-configuration. The molecule contains an N-terminal fluorenylmethoxycarbonyl (Fmoc) protecting group that suppresses amine reactivity during peptide assembly, while the side-chain ureido functionality provides multiple hydrogen-bonding donors and acceptors relevant to molecular recognition and binding-site mimicry. The free carboxyl group is typically present as a protected or activated form in peptide workflows, and the ureido group can participate in carbodiimide-mediated coupling or subsequent derivatization when deprotected/activated. The combination of a chiral amino acid scaffold, a robust N-protecting group, and a highly functional side chain makes Fmoc-L-citrulline a practical chiral intermediate and peptide building block for constructing citrulline-containing sequences and ureido-rich peptidomimetics.

1. Peptide Synthesis

Fmoc-L-citrulline is applied in solid-phase peptide synthesis for incorporating citrulline residues into peptide building blocks with controlled N-terminal reactivity. The Fmoc group enables stepwise N-to-C peptide coupling by masking the alpha-amino functionality until base-promoted deprotection, while the ureido side chain remains available for hydrogen-bonding interactions that can influence coupling efficiency and conformational preferences. The alpha-amino acid stereochemistry is preserved during standard peptide coupling cycles, supporting stereodefined peptide analog construction. Downstream, citrulline-containing peptides prepared from this building block can be used as substrates, reference standards, or sequence-specific tools in biochemical assays and peptide structure studies.

2. Chemical Biology Probes

Fmoc-L-citrulline is suited for chemical biology research where ureido-bearing amino acid analogs help probe arginine/citrulline recognition motifs and post-translational modification pathways. The side-chain urea/ureido functionality can be leveraged for conjugation strategies that introduce polar interaction patterns into probes without requiring drastic changes to backbone stereochemistry. Fmoc protection supports clean incorporation into longer peptide scaffolds, enabling site-defined labeling or the generation of peptide-based recognition elements that mimic citrulline presentation. The resulting citrulline-containing constructs can serve as biochemical research intermediates for studying binding specificity, molecular recognition, and sequence-dependent interaction networks.

3. Peptidomimetics And SAR

Fmoc-L-citrulline is used in peptidomimetic and SAR-oriented molecular design to generate ureido-functional scaffolds that reproduce key hydrogen-bonding features of citrulline side chains. The protected amino acid format supports iterative synthesis of analog series where the ureido group is retained while the backbone context and adjacent residues are systematically varied. The chiral alpha-carbon stereochemistry supports stereodefined analog comparison, which can be important when evaluating structure-function relationships in peptide-like systems. Citruilline-derived intermediates prepared from this building block can be further transformed into constrained analogs or functionalized derivatives for downstream screening and analytical characterization.

4. Bioconjugation Chemistry

Fmoc-L-citrulline is applicable to bioconjugation workflows that require site-specific incorporation of a polar ureido handle into peptide conjugates. The Fmoc-protected alpha amine facilitates controlled peptide assembly prior to conjugation, while the ureido side chain provides a distinct functional motif for subsequent chemical modification or for tuning solubility and interaction strength of the conjugate. Deprotected peptide intermediates derived from this building block can be used to generate conjugation-ready constructs for attaching biomolecule-binding domains, reporters, or affinity tags. The resulting citrulline-containing conjugates support downstream production of labeled biomolecules and analytical reagents used in biochemical research.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-citrulline is relevant to pharmaceutical intermediate preparation where protected amino acids and peptide building blocks are used to construct defined fragments for process chemistry and fine chemical synthesis. The Fmoc group provides a stable N-protection strategy during multistep assembly, while the ureido side chain can be carried through synthesis as a functional group that contributes to polarity and hydrogen-bonding in final intermediates. The chiral amino acid framework supports stereochemically consistent fragment generation for downstream coupling into larger molecules or peptide-like candidates. Process-oriented use can include preparing citrulline-containing intermediates for analytical reference materials, impurity mapping, and controlled synthesis of defined ureido-rich structures.

6. Analytical Research Standards

Fmoc-L-citrulline is used to prepare analytical reference materials and calibration components for chromatographic and mass spectrometric characterization of citrulline-containing peptides and derivatives. The Fmoc-protected form supports consistent incorporation into defined peptide sequences, enabling reproducible generation of standards with controlled stereochemistry and side-chain functionality. The ureido side chain provides a characteristic chemical signature that can improve detectability and structural assignment in analytical workflows. Analytical-grade peptide standards derived from this building block can support method development, identity confirmation, and comparative profiling in biochemical research and industrial quality control contexts.

Abbr
Fmoc-Cit-OH
InChI
InChI=1S/C21H23N3O5/c22-20(27)23-11-5-10-18(19(25)26)24-21(28)29-12-17-15-8-3-1-6-13(15)14-7-2-4-9-16(14)17/h1-4,6-9,17-18H,5,10-12H2,(H,24,28)(H,25,26)(H3,22,23,27)/t18-/m0/s1
InChI Key
NBMSMZSRTIOFOK-SFHVURJKSA-N
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NC(CCCNC(=O)N)C(=O)O

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide Analysis ServicesPeptide Synthesis ServicesEpitope Mapping ServicesPeptide Nucleic Acids SynthesisPeptide Modification ServicesCustom Conjugation ServicePeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers